HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Two ‘Hot Buttons’ Right Now In Product Testing: Benzene In Sunscreens, PFAS In Cosmetics

Executive Summary

Craig Weiss, co-CEO and president of CPT Labs, discusses recent reports driving interest in testing for benzene and PFAS in sunscreens and cosmetic products.

You may also be interested in...



California’s PFAS Ban In Cosmetics Limited To Intentionally Added Substances, Effective In 2025

Legislation awaiting the governor’s signature in California will ban the “forever chemicals” from cosmetics when intentionally added beginning in 2025, reflecting successful industry advocacy efforts.

J&J Commits To Supply Chain Reforms In Benzene Class Action Settlement

Already in receipt of more than $9m in refund requests from purchasers of potentially benzene-contaminated Neutrogena and Aveeno sunscreen products following a July 2021 recall, J&J now is finalizing a US multidistrict class action settlement that will add to those costs and require steps to prevent further benzene issues.

Burt’s Bees Joins Beauty Brands In Court Over PFAS

Plaintiff Daniela Gruen says Burt’s Bees mascaras and lip shimmer are worthless or worth less than purchase price because the company failed to disclose that the products contain toxic and environmentally hazardous PFAS. She cites independent testing published last year by Mamavation in her complaint filed in California’s Northern District.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS151471

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel